FDA Recalls Dozens More Eye Drop Products FDA Recalls Dozens More Eye Drop Products
More than 2 dozen products could cause eye infections or blindness, after bacterial contamination and unsanitary conditions were found at a manufacturing facility, the agency said.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 30, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology News Source Type: news
FDA Approves New Drug for Ulcerative Colitis FDA Approves New Drug for Ulcerative Colitis
Mirikizumab (Omvoh) is the first IL-23 inhibitor to be approved in the United States for the treament of moderately to severely active ulcerative colitis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 27, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news
FDA Approves Mirikizumab for Ulcerative Colitis FDA Approves Mirikizumab for Ulcerative Colitis
Mirikizumab (Omvoh) is the first IL-23 inhibitor to be approved in the United States for the treament of moderately to severely active ulcerative colitis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 27, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news
Tech Encourages HIV Prevention Among Women Tech Encourages HIV Prevention Among Women
Preexposure prophylaxis is highly effective in preventing HIV and yet uptake can be low among women, report researchers who say mobile technologies can help.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 27, 2023 Category: Drugs & Pharmacology Tags: HIV/AIDS News Source Type: news
PCPs and Knee OA: When to Keep Treating, When to Refer PCPs and Knee OA: When to Keep Treating, When to Refer
PCPs are well qualified to manage patients with moderate to severe knee osteoarthritis, but when to refer to a specialist can be a tricky decision.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 26, 2023 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Source Type: news
Higher Weight Loss on Tirzepatide Links to Seven Factors Higher Weight Loss on Tirzepatide Links to Seven Factors
Data from four tirzepatide pivotal trials in people with type 2 diabetes showed ≥15% weight loss in 25% of those on tirzepatide, with seven factors significantly linked with greater weight loss.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 26, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
mRNA Vaccine Cuts COVID-Related Guillain-Barr é Risk mRNA Vaccine Cuts COVID-Related Guillain-Barr é Risk
COVID-19 increases the risk for Guillain-Barr é syndrome sixfold, while getting the Pfizer mRNA vaccine lowers risk.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 26, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news
Racial, Ethnic Differences in Pain Management for Acute Injuries Racial, Ethnic Differences in Pain Management for Acute Injuries
A large US study shows racial and ethnic disparities in how paramedics record and treat pain from acute traumatic injury during prehospital transport.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 26, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news
FDA Warns of Hidden Ingredients in Arthritis, Pain Products FDA Warns of Hidden Ingredients in Arthritis, Pain Products
Certain products may contain active ingredients found in prescription-only drugs.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 25, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Alert Source Type: news
GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin
Among people with type 2 diabetes who received a GLP-1 receptor agonist, there was less correlation between this treatment and thyroid cancer than among people with type 2 diabetes treated with insulin.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 25, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
CBT App for Type 2 Diabetes Hits US Market CBT App for Type 2 Diabetes Hits US Market
A novel smartphone app, AspyreRx, that delivers cognitive-behavioral therapy to adults with type 2 diabetes became available for prescribing to US patients on October 16.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 24, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
Exercise as Good as Viagra for ED: Study Exercise as Good as Viagra for ED: Study
Men with the most severe erectile dysfunction saw the greatest benefit from working out.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 23, 2023 Category: Drugs & Pharmacology Tags: Urology News Source Type: news
Digital Tool Clarifies Menopause Symptoms Digital Tool Clarifies Menopause Symptoms
A website that helps personalize menopause care garnered strong reviews from clinicians in a UK study.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 23, 2023 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Source Type: news
Biologics After Asthma Exacerbation Biologics After Asthma Exacerbation
Although the study was retrospective, it suggests that the threshold for initiating biologics could potentially be lowered for patients with uncontrolled asthma despite adequate use of inhalers.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 19, 2023 Category: Drugs & Pharmacology Tags: Pulmonary Medicine News Source Type: news
Higher Fracture Risk Not Seen With SGLT2 Inhibitors Higher Fracture Risk Not Seen With SGLT2 Inhibitors
Increased fracture risk seen in short-term studies may have been due to hypovolemia or osmotic diuresis, resulting in falls, rather than an effect on bone.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 19, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
